1. Home
  2. UCL vs NEPH Comparison

UCL vs NEPH Comparison

Compare UCL & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo uCloudlink Group Inc.

UCL

uCloudlink Group Inc.

N/A

Current Price

$1.58

Market Cap

74.5M

ML Signal

N/A

Logo Nephros Inc.

NEPH

Nephros Inc.

HOLD

Current Price

$4.56

Market Cap

60.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UCL
NEPH
Founded
2014
1997
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
74.5M
60.0M
IPO Year
2020
2004

Fundamental Metrics

Financial Performance
Metric
UCL
NEPH
Price
$1.58
$4.56
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
14.5K
53.1K
Earning Date
03-12-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
8.06
N/A
EPS
0.12
0.14
Revenue
$85,239,000.00
$17,930,000.00
Revenue This Year
N/A
$33.32
Revenue Next Year
$9.99
$12.27
P/E Ratio
$12.82
$32.34
Revenue Growth
N/A
32.36
52 Week Low
$0.80
$1.39
52 Week High
$4.19
$6.42

Technical Indicators

Market Signals
Indicator
UCL
NEPH
Relative Strength Index (RSI) 39.07 46.23
Support Level $1.54 $4.31
Resistance Level $1.66 $4.82
Average True Range (ATR) 0.08 0.32
MACD -0.00 -0.01
Stochastic Oscillator 12.90 36.47

Price Performance

Historical Comparison
UCL
NEPH

About UCL uCloudlink Group Inc.

Ucloudlink Group Inc is engaged in the provision of data connectivity services and sales of Wi-Fi terminals and data related products to enable personal and enterprise users to access mobile internet in more than 100 countries and areas. Leveraging its inventive cloud SIM technology and architecture, the company redefine the mobile data connectivity experience, allowing users to gain access to mobile data traffic allowance shared by network operators on its marketplace. It has aggregated mobile data traffic allowances from 391 MNOs in 163 countries and regions in its cloud SIM architecture. The company derives maximum revenue from Japan.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: